Aug 28, 2019
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 07, 2019
Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials
Jul 31, 2019
Arena Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on August 7
Jun 13, 2019
Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19
May 17, 2019
Arena Pharmaceuticals' Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease Community
May 13, 2019
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
May 08, 2019
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2019 Financial Results
May 01, 2019
Arena Pharmaceuticals to Release First Quarter 2019 Financial Results and Provide Corporate Update on May 8
Apr 03, 2019
Arena Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 10
Mar 08, 2019
Arena Pharmaceuticals Presented New Phase 2 Data for Etrasimod and Olorinab at the 14th Congress of European Crohn's and Colitis Organisation
Feb 26, 2019
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
Feb 07, 2019
Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn's & Colitis Congress
Jan 24, 2019
Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag
Jan 07, 2019
Arena Pharmaceuticals Reports Positive Long-Term Data from the Open-Label Extension of the Phase 2 OASIS Trial Evaluating Etrasimod for Treatment of Ulcerative Colitis
Dec 19, 2018
Arena Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 10
Dec 17, 2018
Arena Pharmaceuticals Appoints Experienced Life Sciences Industry Finance Executive Manmeet S. Soni to Board of Directors
Nov 26, 2018
Arena Pharmaceuticals Expands Senior Management Team to Support Commercialization and Medical Affairs
Nov 20, 2018
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
Nov 15, 2018
Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag
Nov 13, 2018
Arena Pharmaceuticals Presented Preclinical Data for APD418 in Development for Treatment of Decompensated Heart Failure at American Heart Association Scientific Sessions